Ion Exchange (India) moves up on executing agreement with MANN + HUMMEL
The Agreement has been entered into in the ordinary course of business
Ion Exchange (India) is currently trading at Rs. 400.05, up by 2.95 points or 0.74% from its previous closing of Rs. 397.10 on the BSE.
The scrip opened at Rs. 399.15 and has touched a high and low of Rs. 403.15 and Rs. 394.40 respectively. So far 5352 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 580.65 on 17-Jul-2025 and a 52 week low of Rs. 312.30 on 23-Mar-2026.
Last one week high and low of the scrip stood at Rs. 419.95 and Rs. 317.90 respectively. The current market cap of the company is Rs. 5830.00 crore.
The promoters holding in the company stood at 25.52%, while Institutions and Non-Institutions held 19.43% and 55.05% respectively.
Ion Exchange (India) has executed a Technology Transfer Agreement (Agreement) with MANN + HUMMEL. Under the Agreement, MANN + HUMMEL has, inter alia, agreed to transfer technology for the manufacture of PVDF Ultrafiltration (UF) membranes and Integrated Membrane Bioreactor (MBR) systems.
The Agreement has been entered into in the ordinary course of business and is expected to support the Company’s long-term strategic and technological objectives.
Ion Exchange will manufacture, undertake system integration, and commercialize PVDF hollow fiber ultrafiltration membranes along with integrated UltraSKID systems based on MANN+HUMMEL's advanced technology. Production will take place at Ion Exchange's expanded, state-of-the-art HYDRAMEM membrane manufacturing facility in Goa.
Ion Exchange (India) is one of the best water and environment management solution company in India.

